| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
2,301.35
|
|
Change (%)
|
-21.85 (-0.94%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
2,292.00
-
2,336.00
|
|
52-Week Range (RS)
|
1,774.00
-
2,336.00
|
|
Beta (1 Year)
|
0.83
|
|
|
|
|
|
| Index Details |
| BSE 100, BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Shariah 50, bse carbonex |
| News |
|
Corporate Details |
| Lupin receives EIR report with VAI classification for its Goa unit |
| Lupin gets satisfactory USFDA inspection report for Goa facility |
| Lupin gets USFDA nod for Brivaracetam Oral Solution |
| Lupin receives USFDA approval for Brivaracetam Oral Solution 10 mg/mL |
| Lupin Ltd spurts 1.61% |
| Lupin secures European Commission approval for Ranluspec |
| Lupin receives European Commission approval for Biosimilar Ranibizumab |
| Stock Alert: Lupin, NTPC, Cochin Shipyard, Texmaco Rail & Engineering, BLS E-Services |
| Lupin rises on licensing pact with Spektus Pharma for DeslaFlex in Canada |
| Lupin consolidated net profit rises 37.47% in the December 2025 quarter |
|
|
|
| Incoporation Year : 1983 |
| Chairman : M D Gupta |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Lupin Ltd
Kalpataru Inspire 3rd Floor,
Off Western Exp HW Santacruz-E,
Mumbai,
Maharashtra-400055 |
Phone:91-22-6640 2323
Fax:91-22-6640 8131 |
| E-Mail : investorservices@lupinpharma.com |
URL : https://www.lupin.com
|
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
20-Feb-2026 |
2219.70 |
3.68 |
| 1Month |
27-Jan-2026 |
2147.60 |
7.16 |
| 3Month |
27-Nov-2025 |
2072.40 |
11.05 |
| 6Month |
28-Aug-2025 |
1902.45 |
20.97 |
| 1Year |
27-Feb-2025 |
1891.45 |
21.67 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| HDFC Balanced Advantage Fund |
1.15 |
1224.18 |
| HDFC Large Cap Fund |
2.51 |
993.73 |
| Mirae Asset Large & Midcap Fund |
2.23 |
944.68 |
| HDFC Flexi Cap Fund |
0.93 |
904.18 |
| Nippon India Pharma Fund |
7.88 |
620.87 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Sun Pharmaceutical Industries Ltd |
1,738.10 |
-2.61 |
1,850.95 |
1,547.25 |
417,028.41 |
| Cipla Ltd |
1,347.65 |
-0.75 |
1,672.20 |
1,283.00 |
108,860.56 |
| Dr Reddys Laboratories Ltd |
1,287.20 |
-2.40 |
1,377.95 |
1,025.90 |
107,435.25 |
| Zydus Lifesciences Ltd |
922.50 |
-1.67 |
1,059.00 |
797.05 |
92,825.09 |
| Mankind Pharma Ltd |
2,247.65 |
-1.42 |
2,726.75 |
2,014.85 |
92,784.13 |
|
|
|
|